A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, ...

A new risk score may identify patients with node-negative pancreatic neuroendocrine tumors who face a high risk for ...

An AI model significantly improved recurrence risk stratification vs. recurrence score among patients with hormone ...

The Oncotype DX Breast Recurrence Score® test, which has been used by over 1.5 million patients, indicates the likelihood of your cancer recurring based on the biology of your tumor. 1,2,3,4 It is ...

Please provide your email address to receive an email when new articles are posted on . Oncotype DX Breast Recurrence Score appeared to be associated with mortality at a lower threshold for men with ...

A retrospective study validates the Oncotype 21-gene breast recurrence score as a predictive biomarker of adjuvant chemotherapy benefit in women with estrogen receptor (ER)-positive/human epidermal ...

Known as the 21-gene recurrence score, the test is a personalized analysis of the activity of 21 genes found in a patient's breast tumor tissue. The score can be used to predict whether, after ...

RECKGIST score effectively predicts recurrence in neurofibromatosis type 1-associated GISTs, especially for tumors under 30 mm. Larger GISTs (over 30 mm) have a higher risk of metastasis, with ...

MADISON, Wis., April 28, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced that recommended use of its Oncotype DX Breast Recurrence ...

A new study shows that a test physicians commonly used to guide chemotherapy treatment for post-breast cancer surgery patients may also help them decide whether radiation therapy may be of benefit.

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...